As the global landscape of science and regulation evolves, life sciences companies face increasing pressure to adapt. Phenomenex, a leader in separation sciences, is tackling these challenges through economic strategy, customer collaboration, and innovation.
Economic pressures have intensified with recent changes in US tariffs and international trade policies, affecting raw material costs and logistics. Dr. Kaveh Kahen, president of Phenomenex, highlighted the impact of tariffs on costs and the company’s strategies to manage these pressures, including supply chain optimization.
Innovation at Phenomenex is driven by customer needs, with recent product launches reflecting this focus. The company has introduced microflow HPLC columns for greener chromatography and new Biozen column lines compatible with mass spectrometry. Additionally, Phenomenex has enhanced its e-commerce platform to improve customer experience.
Customer engagement remains a priority, with Phenomenex emphasizing face-to-face interactions and collaborative problem-solving. The company is also staying ahead of trends by working with academic researchers and early adopters through its Open Innovation Team.
Phenomenex is addressing market demands in areas like PFAS analysis and clinical LC-MS, developing solutions to meet regulatory and technical requirements. The company is expanding its presence in emerging markets, particularly in India, to meet growing demand for analytical tools.
Looking to the future, Phenomenex is exploring AI to enhance operations and customer solutions. By combining customer engagement, innovation, and market responsiveness, the company aims to lead in analytical science and shape the industry’s future.
